Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AERs To Go Online: Drug Safety Budget Proposal Funds Web Version

This article was originally published in The Tan Sheet

Executive Summary

FDA is proposing increased drug safety funding to launch its web-accessible, second-generation Adverse Event Reporting System

You may also be interested in...



FDA’s Sentinel initiative

FDA will tap Medicare Part D's large-scale claims database for the pilot phase of its Sentinel post-market drug safety surveillance initiative, Health and Human Services Secretary Mike Leavitt announced May 22. The Sentinel initiative aims to create a national electronic system for monitoring the safety of drugs and devices, and will also incorporate elements of FDA's Adverse Event Reporting system (1"The Tan Sheet" Feb. 20, 2006, p. 5). A 2white paper also released May 22 does not indicate when a full-scale network of participants will be ready, but notes the agency will start using Part D data as soon as practicable to launch the project...

FDA’s Sentinel initiative

FDA will tap Medicare Part D's large-scale claims database for the pilot phase of its Sentinel post-market drug safety surveillance initiative, Health and Human Services Secretary Mike Leavitt announced May 22. The Sentinel initiative aims to create a national electronic system for monitoring the safety of drugs and devices, and will also incorporate elements of FDA's Adverse Event Reporting system (1"The Tan Sheet" Feb. 20, 2006, p. 5). A 2white paper also released May 22 does not indicate when a full-scale network of participants will be ready, but notes the agency will start using Part D data as soon as practicable to launch the project...

FDA’s Sentinel initiative

FDA will tap Medicare Part D's large-scale claims database for the pilot phase of its Sentinel post-market drug safety surveillance initiative, Health and Human Services Secretary Mike Leavitt announced May 22. The Sentinel initiative aims to create a national electronic system for monitoring the safety of drugs and devices, and will also incorporate elements of FDA's Adverse Event Reporting system (1"The Tan Sheet" Feb. 20, 2006, p. 5). A 2white paper also released May 22 does not indicate when a full-scale network of participants will be ready, but notes the agency will start using Part D data as soon as practicable to launch the project...

Related Content

Topics

UsernamePublicRestriction

Register

PS099101

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel